An environmental wide association study (EWAS) approach to the metabolic syndrome

Environment International

Volumn 55, Issue , 2013, Pages 1-8

  Lind, P Monica ^a   Risérus, Ulf ^b   Salihovic, Samira ^c   Bavel, Bert van ^c   Lind, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY   (Sweden)

Author keywords

Dietary records; Environmental contaminants; Exercise habits; Fatty acids; Lifestyle factors; Metabolic syndrome

Indexed keywords

FATTY ACIDS; LINOLEIC ACID; METABOLISM; OLEIC ACID; PALMITIC ACID; QUALITY CONTROL;

DIETARY RECORDS; ENVIRONMENTAL CONTAMINANT; EXERCISE HABITS; LIFESTYLE FACTORS; METABOLIC SYNDROMES;

CONTAMINATION;

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,3,3',4,4' PENTACHLOROBIPHENYL; BIPHENYL DERIVATIVE; CHOLESTEROL; DECACHLOROBIPHENYL; LINOLEIC ACID; NONACHLORDANE; OLEIC ACID; PALMITIC ACID; PHTHALIC ACID; UNCLASSIFIED DRUG;

DIET; ELDERLY POPULATION; FATTY ACID; HEALTH RISK; LIFESTYLE; METABOLISM; PHYSICAL ACTIVITY; POLLUTION EXPOSURE;

AGED; ARTICLE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL WIDE ASSOCIATION STUDY; EXERCISE; FAT INTAKE; FEMALE; GERIATRIC NUTRITION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLLUTANT; PREVALENCE; PRIORITY JOURNAL;

SWEDEN; UPPSALA [SWEDEN];

EID: 84874548469     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.01.017     Document Type: Article

References (43)

1. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association 1998, 15(7):539-553.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA: The Journal of the American Medical Association 2001, 285(19):2486-2497.
3. Blair A., Saracci R., Vineis P., Cocco P., Forastiere F., Grandjean P., et al. Epidemiology, public health, and the rhetoric of false positives. Environmental Health Perspectives 2009, 117(12):1809-1813.
4. Boberg M., Croon L.B., Gustafsson I.B., Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clinical Science (London, England) 1985, 68(5):581-587.
5. Boffetta P., McLaughlin J.K., La Vecchia C., Tarone R.E., Lipworth L., Blot W.J. False-positive results in cancer epidemiology: a plea for epistemological modesty. Journal of the National Cancer Institute 2008, 100(14):988-995.
6. Dirinck E., Jorens P.G., Covaci A., Geens T., Roosens L., Neels H., et al. Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) 2011, 19(4):709-714.
7. Fallin M.D., Kao W.H. Is "X"-WAS the future for all of epidemiology?. Epidemiology 2011, 22(4):457-459. [discussion 467-458].
8. Hatch E.E., Nelson J.W., Stahlhut R.W., Webster T.F. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. International Journal of Andrology 2010, 33(2):324-332.
9. Ioannidis J.P. Why most published research findings are false. PLoS Medicine 2005, 2(8):e124.
10. Ioannidis J.P. Why most discovered true associations are inflated. Epidemiology 2008, 19(5):640-648.
11. Ioannidis J.P., Loy E.Y., Poulton R., Chia K.S. Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification. Science Translational Medicine 2009, 1(7). [7ps8].
12. Lee D.H., Lee I.K., Porta M., Steffes M., Jacobs D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007, 50(9):1841-1851.
13. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environmental Health Perspectives 2010, 118(9):1235-1242.
14. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PloS One 2011, 6(1):e15977.
15. Lee D.H., Lind L., Jacobs D.R., Salihovic S., van Bavel B., Lind P.M. Associations of persistent organic pollutants with abdominal obesity in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environment International 2012, 40:170-178.
16. Lind L., Jakobsson S., Lithell H., Wengle B., Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 1988, 297(6654):960-963.
17. Lind L., Fors N., Hall J., Marttala K., Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25(11):2368-2375.
18. Lind P.M., Zethelius B., Lind L. Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly. Diabetes Care 2012, 35(7):1519-1524.
19. Lind P.M., Roos V., Ronn M., Johansson L., Ahlstrom H., Kullberg J., et al. Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women. Environmental health: a global access science source 2012, 11:21.
20. Lind P.M., Lee D.H., Jacobs D.R., Salihovic S., Bavel B., Wolff M.S., et al. Circulating levels of persistent organic pollutants are related to retrospective assessment of life-time weight change. Chemosphere 2013, 90(3):998-1004.
21. Ma J., Folsom A.R., Shahar E., Eckfeldt J.H. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. The American Journal of Clinical Nutrition 1995, 62(3):564-571.
22. Ohrvall M., Berglund L., Salminen I., Lithell H., Aro A., Vessby B. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19years follow-up. Atherosclerosis 1996, 127(1):65-71.
23. Olsen L., Lind P.M., Lind L. Gender differences for associations between circulating levels of metals and coronary risk in the elderly. International Journal of Hygiene and Environmental Health 2012, 215(3):411-417.
24. Olsen L., Lampa E., Birkholz D.A., Lind L., Lind P.M. Circulating levels of bisphenol A (BPA) and phthalates in an elderly population in Sweden, based on the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). Ecotoxicology and Environmental Safety 2012, 75(1):242-248.
25. Patel C.J., Bhattacharya J., Butte A.J. An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PloS One 2010, 5(5):e10746.
26. Patel C.J., Cullen M.R., Ioannidis J.P., Butte A.J. Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. International Journal of Epidemiology 2012, 41(3):828-843.
27. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(12):1595-1607.
28. Rignell-Hydbom A., Elfving M., Ivarsson S.A., Lindh C., Jonsson B.A., Olofsson P., et al. A nested case-control study of intrauterine exposure to persistent organochlorine pollutants in relation to risk of type 1 diabetes. PloS One 2010, 5(6):e11281.
29. Rodushkin I., Axelsson M.D. Application of double focusing sector field ICP-MS for multielemental characterization of human hair and nails. Part III. Direct analysis by laser ablation. The Science of the Total Environment 2003, 305(1-3):23-39.
30. Ronn M., Lind L., van Bavel B., Salihovic S., Michaelsson K., Lind P.M. Circulating levels of persistent organic pollutants associate in divergent ways to fat mass measured by DXA in humans. Chemosphere 2011, 85(3):335-343.
31. Roos V, Ronn M, Salihovic S, Lind L, Bavel BV, Kullberg J, et al. Circulating levels of pesistent organic pollutants in relation to visceral and subcutaneous adipose tissue by abdominal MRI. Obesity (Silver Spring) in press. [Epub ahead of print, PMID: 22627916]. http://dx.doi.org/10.1038/oby.2012.123.
32. Ruzzin J., Petersen R., Meugnier E., Madsen L., Lock E.J., Lillefosse H., et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environmental Health Perspectives 2010, 118(4):465-471.
33. Salihovic S., Mattioli L., Lindstrom G., Lind L., Lind P.M., van Bavel B. A rapid method for screening of the Stockholm Convention POPs in small amounts of human plasma using SPE and HRGC/HRMS. Chemosphere 2012, 86(7):747-753.
34. Sandau C.D., Sjodin A., Davis M.D., Barr J.R., Maggio V.L., Waterman A.L., et al. Comprehensive solid-phase extraction method for persistent organic pollutants. Validation and application to the analysis of persistent chlorinated pesticides. Analytical Chemistry 2003, 75(1):71-77.
35. Sergeev A.V., Carpenter D.O. Exposure to persistent organic pollutants increases hospitalization rates for myocardial infarction with comorbid hypertension. Primary prevention insights 2010, 2:1-9.
36. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environmental Health Perspectives 2007, 115(6):876-882.
37. Tzoulaki I., Patel C.J., Okamura T., Chan Q., Brown I.J., Miura K., et al. A nutrient-wide association study on blood pressure. Circulation 2012, 126(21):2456-2464.
38. Uemura H., Arisawa K., Hiyoshi M., Kitayama A., Takami H., Sawachika F., et al. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environmental Health Perspectives 2009, 117(4):568-573.
39. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48(10):1999-2005.
40. Warensjo E., Sundstrom J., Lind L., Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. The American Journal of Clinical Nutrition 2006, 84(2):442-448.
41. Warensjo E., Riserus U., Gustafsson I.B., Mohsen R., Cederholm T., Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutrition, metabolism, and cardiovascular diseases: NMCD 2008, 18(10):683-690.
42. Wolff M.S., Anderson H.A., Britton J.A., Rothman N. Pharmacokinetic variability and modern epidemiology-the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007, 16(10):1925-1930.
43. Young S.S. Acknowledge and fix the multiple testing problem. International Journal of Epidemiology 2010, 39(3):934. [author reply 934-935].